- Home
- EDIT vs ARBE Comparison
EDIT vs ARBE Comparison
Compare EDIT & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- ARBE
- Stock Information
- Founded
- EDIT 2013
- ARBE 2015
- Country
- EDIT United States
- ARBE Israel
- Employees
- EDIT N/A
- ARBE N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- ARBE EDP Services
- Sector
- EDIT Health Care
- ARBE Technology
- Exchange
- EDIT Nasdaq
- ARBE Nasdaq
- Market Cap
- EDIT 179.1M
- ARBE 203.2M
- IPO Year
- EDIT 2016
- ARBE N/A
- Fundamental
- Price
- EDIT $2.88
- ARBE $1.56
- Analyst Decision
- EDIT Buy
- ARBE Buy
- Analyst Count
- EDIT 12
- ARBE 2
- Target Price
- EDIT $6.20
- ARBE $1.75
- AVG Volume (30 Days)
- EDIT 3.5M
- ARBE 1.5M
- Earning Date
- EDIT 08-06-2025
- ARBE 08-05-2025
- Dividend Yield
- EDIT N/A
- ARBE N/A
- EPS Growth
- EDIT N/A
- ARBE N/A
- EPS
- EDIT N/A
- ARBE N/A
- Revenue
- EDIT $35,837,000.00
- ARBE $671,000.00
- Revenue This Year
- EDIT N/A
- ARBE $285.16
- Revenue Next Year
- EDIT N/A
- ARBE $370.11
- P/E Ratio
- EDIT N/A
- ARBE N/A
- Revenue Growth
- EDIT N/A
- ARBE N/A
- 52 Week Low
- EDIT $0.91
- ARBE $0.85
- 52 Week High
- EDIT $6.05
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- EDIT 74.64
- ARBE 45.68
- Support Level
- EDIT $2.48
- ARBE $1.43
- Resistance Level
- EDIT $3.24
- ARBE $1.80
- Average True Range (ATR)
- EDIT 0.25
- ARBE 0.12
- MACD
- EDIT 0.07
- ARBE -0.02
- Stochastic Oscillator
- EDIT 84.84
- ARBE 25.10
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.